The use of perfluoro-octane in the management of giant retinal tears without proliferative vitreoretinopathy.

Abstract

PURPOSE:

A technique for managing giant retinal tears without proliferative vitreoretinopathy (PVR) is presented, and visual outcome, anatomic reattachment, and postoperative complications are discussed.

METHODS:

A total of 25 consecutive cases of retinal detachment from giant retinal tears in eyes without PVR that had not previously undergone surgery were reviewed. A surgical technique combining pars plana vitrectomy, perfluoro-octane, and fluid-gas exchange was used. Scleral buckling was performed in 23 (92%) of 25 eyes, and pars plana lensectomy was performed in 11 (69%) of the 16 phakic eyes. A minimum follow-up period of 6 months was documented in each case.

RESULTS:

Of the 25 eyes, redetachment occurred in 3 (12%) after the initial procedure, and further surgery was necessary to successfully reattach the retina. A total of 9 secondary procedures were performed in 7 (28%) of the 25 eyes. Final retinal reattachment was achieved in all 25 eyes. Final Snellen visual acuity was 20/80 or better in 18 (72%) patients and 20/200 or better in 21 (84%) patients.

CONCLUSION:

The anatomic and visual results of this method of surgical treatment of giant retinal tears without PVR compare favorably to those achieved with techniques that use a nonbuckling approach, but with reduced ocular morbidity.

• Authors: D Ie, B M Glaser, R N Sjaarda, J T Thompson, L E Steinberg, L W Gordon
• Journal: Retina (Philadelphia, Pa.) (Retina) Vol. 14 Issue 4 Pg. 323-8 ( 1994) ISSN: 0275-004X [Print] United States
• PMID: 7817025 (Publication Type: Journal Article)

Chemical References

• Fluorocarbons
• perfluorooctane

Topics

• Adolescent
• Adult
• Aged
• Child
• Female
• Fluorocarbons
• Follow-Up Studies
• Humans
• Lens, Crystalline (surgery)
• Male
• Middle Aged
• Reoperation
• Retinal Detachment (etiology, surgery)
• Retinal Perforations (complications, surgery)
• Scleral Buckling
• Visual Acuity
• Vitrectomy
• Vitreoretinopathy, Proliferative (etiology)